Privium Fund Management B.V. Fusion Pharmaceuticals Inc. Transaction History

Privium Fund Management B.V.

  • $401 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024
BUY
$7.9 - $21.32 $864,323 - $2.33 Million
109,408 Added 77.18%
251,158 $5.35 Million
Q4 2023

Feb 13, 2024
BUY
$2.48 - $9.65 $351,540 - $1.37 Million
141,750 New
141,750 $1.36 Million

Others Institutions Holding FUSN

# of Institutions
5
Shares Held
93K
Call Options Held
1.4K
Put Options Held
0
View Full List

About Fusion Pharmaceuticals Inc.

FUSN Quotes by TradingView
  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track This Portfolio

Track Privium Fund Management B.V. Portfolio

Follow Privium Fund Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Privium Fund Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Privium Fund Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email